“Antimicrobial Peptide PR39 Alleviates Colitis in Mice: Implications for Inflammatory Bowel Disease Treatment”

https://pubmed.ncbi.nlm.nih.gov/38113690

The antimicrobial peptide PR39 alleviates symptoms of dextran sulfate-induced colitis in mice by modulating the NF-κB/MAPK signaling pathway and intestinal flora, suggesting its potential as a novel treatment for inflammatory bowel disease.